ˇ
Z. Hamersak et al.
layers were separated and the organic layer was washed with brine
(10 mL). The organic layer was dried over Na2SO4, filtered, and concen-
trated under vacuum. Compound 21 was isolated as an orange powder
after chromatography (360 mg, 68%). Rf =0.2 (hexane/EtOAc 9:1); m.p.
119–1208C; 1H NMR (300 MHz, CDCl3): d=0.11 (s, 9H), 1.19–1.25 (m,
2H), 3.28–3.34 (m, 2H), 7.59–7.60 (m, 2H), 7.72–7.77 (m, 2H), 8.11 (d,
J=8.0 Hz, 2H), 8.76 (s, 1H), 9.04 (d, J=8.0 Hz, 2H), 10.45 ppm (s, 1H);
13C NMR (75 MHz, CDCl3): d=À2.0, 9.8, 49.2, 121.1, 124.2, 125.9, 129.6,
129.7, 131.1, 133.1, 136.6, 170.3 ppm; IR (KBr): n˜ =2950, 1581, 1314,
gel chromatography (88 mg, 61%); Rf =0.39 (hexane/EtOAc 8:1). Prod-
uct 36 was a pure cis isomer: ee 98% (Chiralcel OJ; hexane/2-propanol
95:5; 210 nm; 1 mLminÀ1; tminor =7.2 min, tmajor =10.1 min); [a]2D5 =À133
1
(c=1.09 in CHCl3); H NMR (300 MHz, CDCl3): d=0.08 (s, 9H), 0.80 (s,
9H), 1.22–1.29 (m, 2H), 2.82 (d, J=7.6 Hz, 1H), 3.15–3.21 (m, 2H), 3.91
(d, J=7.6 Hz, 1H), 7.27–7.38 ppm (m, 5H); 13C NMR (75 MHz, CDCl3):
d=À1.8, 10.1, 27.9, 32.3, 46.2, 49.0, 53.6, 127.8, 128.5, 134.0 ppm; IR
(KBr): n˜ =3062, 3033, 2956, 1328, 1250, 1141 cmÀ1; elemental analysis
calcd (%) for C17H29NO2SSi (339): C 60.13, H 8.61, N 4.12; found: C
60.52, H 8.54, N 3.89. Data are in the accordance with the literature.[3c]
1248, 1137, 859, 795 cmÀ1
.
2-Phenyl-3-(9-phenanthryl)-1-(2-trimethylsilylethanesulfonyl)aziridine
(38): NaH (36 mg, 60% dispersion in paraffin, 0.9 mmol, 2 equiv) was
added to a stirred solution of benzyl sulfonium salt 1 (198 mg, 0.45 mmol,
1.1 equiv) under argon in anhydrous THF (8 mL), cooled to À408C.
After 1 h, a solution of 18 (150 mg, 0.40 mmol, 1 equiv) in THF (2 mL)
was added dropwise. The reaction mixture was stirred for 20 h at À408C,
then cold H2O (15 mL) was added, and the mixture was extracted with
dichloromethane (3ꢄ10 mL). The combined organic extracts were dried
over Na2SO4, filtered, and concentrated under vacuum. The crude prod-
uct was analyzed by 1H NMR spectroscopy to determine the diastereo-
meric ratio and then purified by column chromatography on silica gel
eluting with hexane/EtOAc 8:1. The first fraction contained recovered
(R,R,R)-oxathiane 3 (72 mg, 90%); Rf =0.8 (hexane/EtOAc 8:2). The
title compound 38 was isolated as a yellow oil (145 mg, 80%); Rf =0.21
(hexane/EtOAc 8:1). Isomers of 38 were separated by chiral HPLC.
Trans isomer: ee>97% (Chiralpak AD; hexane/ethanol 97:3; 254 nm;
2-Phenyl-3-(4-methoxyphenyl)-1-(2-nitrobenzenesulfonyl)aziridine (31):
Prepared as described above starting from 11 (100 mg, 0.31 mmol), and
isolated as a light-yellow powder after workup and chromatography on
neutral alumina, activity I (70 mg, 55%); Rf =0.35 (hexane/EtOAc 7:3).
Although the crude product 31 was a cis/trans (61:39) mixture, after chro-
matography, only the cis isomer was isolated. Cis isomer: ee 99% (Chir-
alcel OD; hexane/2-propanol 80:20; 229 nm; 1 mLminÀ1; tminor =28.0 min,
t
major =31.2 min); m.p. 128.2–128.88C; 1H NMR (300 MHz, CDCl3): d=
3.69 (s, 3H), 4.40 (d, J=7.3 Hz, 1H), 4.43 (d, J=7.3 Hz, 1H), 6.66–6.69
(m, 2H), 7.02–7.03 (m, 2H), 7.12–7.14 (m, 2H), 7.15–7.17 (m, 3H), 7.75–
7.77 (m, 3H), 8.29–8.31 ppm (m, 1H); 13C NMR (75 MHz, CDCl3): d=
49.1, 49.3, 55.1, 113.5, 123.7, 124.6, 127.9, 127.9, 128.1, 129.1, 131.4, 131.8,
131.8, 132.2, 134.6, 159.3 ppm; IR (KBr): n˜ =3093, 2935, 1544, 1515, 1364,
1341, 1252, 1169, 1127, 1028 cmÀ1; elemental analysis calcd (%) for
C21H18N2O5S (410): C 61.45, H 4.42, N 6.83; found: C 61.15, H 4.68, N
6.55.
1 mLminÀ1
; tmajor =21.9 min, t
minor =25.3 min); [a]2D5 =+54 (c=0.57 in
2-Phenyl-3-(1-naphthyl)-1-(2-nitrobenzenesulfonyl)aziridine (35): Pre-
pared as described above starting from 15 (120 mg, 0.35 mmol), and iso-
lated as a light-brown viscous oil after workup and chromatography
(102 mg, 65%); Rf =0.27 (hexane/EtOAc 7:3). Product 35 was obtained
as a cis/trans mixture. Isomers of 35 were separated by chiral HPLC.
Trans isomer: ee 98% (Chiralcel OD; hexane/ethanol 80:20; 254 nm;
CHCl3); 1H NMR (300 MHz, CDCl3): d=À0.04 (s, 9H), 1.07–1.13 (m,
2H), 2.95–3.14 (m, 2H), 4.36 (d, J=4.8 Hz, 1H), 4.84 (d, J=4.8 Hz, 1H),
7.42–7.49 (m, 3H), 7.61–7.72 (m, 6H), 7.91 (dd, J1 =7.8, J2 =1.5 Hz, 1H),
7.94 (s, 1H), 8.29–8.33 (m, 1H), 8.69 (d, J=8.0 Hz, 1H), 8.74–8.77 ppm
(m, 1H); 13C NMR (75 MHz, CDCl3): d=À2.1, 9.7, 48.7, 49.7, 51.1, 122.6,
123.3, 124.4, 126.4, 127.0, 127.0, 127.0, 127.4, 128.4, 128.5, 128.8, 129.0,
129.1, 130.6, 130.6, 130.9, 131.1, 133.1 ppm; IR (KBr): n˜ =3067, 2953,
1715, 1448, 1323, 1246, 1143, 844 cmÀ1. Cis isomer: ee 97% (Chiralpak
1 mLminÀ1 minor =20.6 min); [a]2D5 =+258 (c=0.55 in
; tmajor =17.3 min, t
CH2Cl2); 1H NMR (300 MHz, CDCl3): d=4.52 (d, J=5.0 Hz, 1H), 4.97
(d, J=5.0 Hz, 1H), 7.38–7.43 (m, 4H), 7.48–7.54 (m, 4H), 7.60–7.65 (m,
4H), 7.80 (d, J=8.3 Hz, 1H), 7.87–7.84 (m, 2H), 8.14–8.15 ppm (m, 1H);
13C NMR (75 MHz, CDCl3): d=50.9, 51.4, 123.5, 124.2, 125.2, 125.3,
126.1, 126.7, 128.3, 128.7, 128.7, 129.0, 129.1, 129.5, 130.8, 131.8, 132.5,
132.9, 133.2, 133.4, 134.0 ppm; IR (KBr): n˜ =3065, 1541, 1367, 1341, 1166,
781 cmÀ1. Cis isomer: ee 97% (Chiralcel OD; hexane/ethanol 90:10;
254 nm; 1 mLminÀ1; tminor =21.3 min, tmajor =27.9 min); [a]2D5 =+203 (c=
0.36 in CH2Cl2); 1H NMR (300 MHz, CDCl3): d=4.69 (d, J=7.3 Hz,
1H), 4.96 (d, J=7.3 Hz, 1H), 6.99–7.01 (m, 3H), 7.11–7.15 (m, 2H),
7.30–7.35 (m, 1H), 7.41–7.56 (m, 4H), 7.67–7.70 (m, 1H), 7.75–7.78 (m,
1H), 7.81–7.82 (m, 2H), 8.02–8.04 (m, 1H), 8.36–8.39 ppm (m, 1H);
13C NMR (75 MHz, CDCl3): d=48.5, 46.6, 122.8, 124.7, 125.0, 125.8,
126.4, 127.3, 127.3, 127.8, 127.9, 128.5, 128.6, 131.1, 131.5, 131.6, 131.7,
132.3, 133.1, 134.8 ppm; IR (KBr): n˜ =3062, 1544, 1367, 1341, 1169, 1127,
AD; hexane/ethanol 97:3; 254 nm; 1 mLminÀ1; tmajor =13.4 min, tminor
=
16.5 min); [a]2D5 =+29 (c=0.61 in CHCl3); 1H NMR (300 MHz, CDCl3):
d=0.07 (s, 9H), 1.29–1.32 (m, 2H), 3.33–3.36 (m, 2H), 4.44 (d, J=
7.3 Hz, 1H), 4.68 (d, J=7.3 Hz, 1H), 6.99–7.01 (m, 3H), 7.19–7.21 (m,
2H), 7.56–7.62 (m, 4H), 7.86 (dd, J1 =7.9, J2 =1.1 Hz, 1H), 7.89 (s, 1H),
8.10–8.12 (m, 1H), 8.58 (d, J=8.0 Hz, 1H), 8.60–8.62 ppm (m, 1H);
13C NMR (75 MHz, CDCl3): d=À2.5, 9.5, 45.8, 47.0, 48.8, 122.0, 122.6,
123.1, 125.8, 126.2, 126.3, 126.3, 126.4, 126.7, 126.8, 127.4, 128.2, 129.6,
129.7, 130.5, 131.5 ppm; IR (KBr): n˜ =3067, 2958, 1690, 1450, 1328, 1252,
1145, 833 cmÀ1; elemental analysis calcd (%) for cis/trans mixture of
C27H29NO2SSi (459): C 70.55, H 6.36, N 3.05; found: C 70.64, H 6.64, N
3.11.
2-Phenyl-3-(9-anthryl)-1-(2-trimethylsilylethanesulfonyl)aziridine
(41):
Compound 41 was prepared as described above starting from 21 (150 mg,
0.42 mmol), and isolated as a yellow oil after workup and silica gel chro-
matography (100 mg, 53%); Rf =0.15 (hexane/CH2Cl2/methyl tert-butyl
ether 8:1:1). Product 41 was obtained as a cis/trans mixture (9:91). Iso-
mers of 41 were separated by chiral HPLC and the assignments below
are for the major trans isomer. Trans isomer: ee 98% (Chiralpak AD;
906 cmÀ1
; elemental analysis calcd (%) for cis/trans mixture of
C24H18N2O4S (430): C 66.96, H 4.21, N 6.51; found: C 66.78, H 4.56, N
6.82.
2-Phenyl-3-(9-phenanthryl)-1-(2-nitrobenzenesulfonyl)aziridine (40): Pre-
pared as described above starting from 20 (100 mg, 0.25 mmol), and iso-
lated as a light-brown viscous oil after workup and chromatography
(93 mg, 76%); Rf =0.26 (hexane/EtOAc 7:3). Product 40 was a cis/trans
mixture. Isomers of 40 were separated by HPLC. Trans isomer: ee 98%
(Chiralcel OD; hexane/2-propanol/diethylamine 50:50:0.2; 254 nm;
hexane/ethanol 95:5; 370 nm; 1 mLminÀ1
;
tmajor =13.7 min, tminor =
18.3 min); [a]2D5 =+39 (c=0.69 in CH2Cl2); 1H NMR (300 MHz, CDCl3):
d=À0.09 (s, 9H), 0.93–1.06 (m, 2H), 2.87–2.99 (m, 2H), 4.41 (d, J=
5.0 Hz, 1H), 5.20 (d, J=5.0 Hz, 1H), 7.46–7.51 (m, 3H), 7.52–7.55 (m,
4H), 7.73–7.75 (m, 2H), 8.02 (dd, J1 =8.0, J2 =0.4 Hz, 2H), 8.48–8.50 ppm
(m, 3H); 13C NMR (75 MHz, CDCl3): d=À2.7, 8.9, 47.6, 50.2, 50.4, 124.3,
124.6, 124.6, 125.8, 128.2, 128.5, 128.6, 128.7, 128.8, 130.4, 130.8,
132.6 ppm; IR (KBr): n˜ =3065, 2952, 1679, 1331, 1285, 1251, 1143, 859,
1 mLminÀ1
;
t
major =45.4 min,
t
minor =72.4 min); 1H NMR (600 MHz,
CDCl3): d=4.59 (d, J=5.0 Hz, 1H), 4.98 (d, J1 =5.0 Hz, 1H), 7.40–7.50
(m, 4H), 7.53–7.69 (m, 8H), 7.79 (brs, 1H), 7.81–7.84 (m, 2H), 8.21 (d,
J=7.6 Hz, 1H), 8.67 (d, J=8.1 Hz, 1H), 8.72 ppm (d, J=8.1 Hz, 1H);
13C NMR (75 MHz, CDCl3): d=50.6, 51.0, 122.1, 122.7, 123.7, 123.9,
126.2, 126.4, 126.4, 126.5, 126.8, 127.0, 127.2, 127.9, 128.3, 128.6, 128.6,
129.9, 130.2, 130.4, 130.4, 130.5, 131.3, 132.3, 132.6, 133.6 ppm; IR (KBr):
n˜ =3064, 2925, 1543, 1364, 1341, 1164, 1127 cmÀ1. Cis isomer: ee 98%
(Chiralcel OD; hexane/2-propanol/diethylamine 50:50:0.2; 254 nm;
1 mLminÀ1; tmajor =24.2 min, tminor =31.2 min); [a]2D5 =+16.7 (c=0.54 in
CH2Cl2); 1H NMR (300 MHz, CDCl3): d=4.72 (d, J=7.3 Hz, 1H), 4.92
843 cmÀ1
; elemental analysis calcd (%) for cis/trans mixture of
C27H29NO2SSi (459): C 70.55, H 6.36, N 3.05; found: C 70.85, H 6.56, N
2.74.
2-Phenyl-3-(tert-butyl)-1-(2-trimethylsilylethanesulfonyl)aziridine
(36):
Compound 36 was prepared as described above starting from 16 (120 mg,
0.48 mmol), and isolated as a colorless viscous oil after workup and silica
11750
ꢂ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 11744 – 11752